Home Medical Devices In Vivo CRO Market Size, Share & Growth Report by 2033

In Vivo CRO Market Size & Outlook, 2025-2033

In Vivo CRO Market Size, Share & Trends Analysis Report By Type (Rodent, Non-Rodent), By Disease Indication (Autoimmune/inflammation conditions, Pain management, Oncology, CNS conditions, Diabetes, Obesity, Others), By GLP Type (Non GLP, GLP Toxicology) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRMD55438DR
Last Updated : May, 2025
Pages : 110
Author : Jay Mehta
Format : PDF, Excel

Market Segmentation

  1. In Vivo CRO Market, By Type (2021-2033)
    1. Rodent
    2. Non-Rodent
  2. In Vivo CRO Market, By Disease Indication (2021-2033)
    1. Autoimmune/inflammation conditions
    2. Pain management
    3. Oncology
    4. CNS conditions
    5. Diabetes
    6. Obesity
    7. Others
  3. In Vivo CRO Market, By GLP Type (2021-2033)
    1. Non GLP
    2. GLP Toxicology
    1. North America
      1. North America In Vivo CRO Market, By Type
        1. Rodent
          1. Non-Rodent
          2. North America In Vivo CRO Market, By Disease Indication
            1. Autoimmune/inflammation conditions
              1. Pain management
                1. Oncology
                  1. CNS conditions
                    1. Diabetes
                      1. Obesity
                        1. Others
                        2. North America In Vivo CRO Market, By GLP Type
                          1. Non GLP
                            1. GLP Toxicology
                            2. U.S.
                              1. U.S. In Vivo CRO Market, By Type
                                1. Rodent
                                  1. Non-Rodent
                                  2. U.S. In Vivo CRO Market, By Disease Indication
                                    1. Autoimmune/inflammation conditions
                                      1. Pain management
                                        1. Oncology
                                          1. CNS conditions
                                            1. Diabetes
                                              1. Obesity
                                                1. Others
                                                2. U.S. In Vivo CRO Market, By GLP Type
                                                  1. Non GLP
                                                    1. GLP Toxicology
                                                  2. Canada
                                                3. Europe
                                                  1. Europe In Vivo CRO Market, By Type
                                                    1. Rodent
                                                      1. Non-Rodent
                                                      2. Europe In Vivo CRO Market, By Disease Indication
                                                        1. Autoimmune/inflammation conditions
                                                          1. Pain management
                                                            1. Oncology
                                                              1. CNS conditions
                                                                1. Diabetes
                                                                  1. Obesity
                                                                    1. Others
                                                                    2. Europe In Vivo CRO Market, By GLP Type
                                                                      1. Non GLP
                                                                        1. GLP Toxicology
                                                                        2. U.K.
                                                                          1. U.K. In Vivo CRO Market, By Type
                                                                            1. Rodent
                                                                              1. Non-Rodent
                                                                              2. U.K. In Vivo CRO Market, By Disease Indication
                                                                                1. Autoimmune/inflammation conditions
                                                                                  1. Pain management
                                                                                    1. Oncology
                                                                                      1. CNS conditions
                                                                                        1. Diabetes
                                                                                          1. Obesity
                                                                                            1. Others
                                                                                            2. U.K. In Vivo CRO Market, By GLP Type
                                                                                              1. Non GLP
                                                                                                1. GLP Toxicology
                                                                                              2. Germany
                                                                                              3. France
                                                                                              4. Spain
                                                                                              5. Italy
                                                                                              6. Russia
                                                                                              7. Nordic
                                                                                              8. Benelux
                                                                                              9. Rest of Europe
                                                                                            3. APAC
                                                                                              1. APAC In Vivo CRO Market, By Type
                                                                                                1. Rodent
                                                                                                  1. Non-Rodent
                                                                                                  2. APAC In Vivo CRO Market, By Disease Indication
                                                                                                    1. Autoimmune/inflammation conditions
                                                                                                      1. Pain management
                                                                                                        1. Oncology
                                                                                                          1. CNS conditions
                                                                                                            1. Diabetes
                                                                                                              1. Obesity
                                                                                                                1. Others
                                                                                                                2. APAC In Vivo CRO Market, By GLP Type
                                                                                                                  1. Non GLP
                                                                                                                    1. GLP Toxicology
                                                                                                                    2. China
                                                                                                                      1. China In Vivo CRO Market, By Type
                                                                                                                        1. Rodent
                                                                                                                          1. Non-Rodent
                                                                                                                          2. China In Vivo CRO Market, By Disease Indication
                                                                                                                            1. Autoimmune/inflammation conditions
                                                                                                                              1. Pain management
                                                                                                                                1. Oncology
                                                                                                                                  1. CNS conditions
                                                                                                                                    1. Diabetes
                                                                                                                                      1. Obesity
                                                                                                                                        1. Others
                                                                                                                                        2. China In Vivo CRO Market, By GLP Type
                                                                                                                                          1. Non GLP
                                                                                                                                            1. GLP Toxicology
                                                                                                                                          2. Korea
                                                                                                                                          3. Japan
                                                                                                                                          4. India
                                                                                                                                          5. Australia
                                                                                                                                          6. Singapore
                                                                                                                                          7. Taiwan
                                                                                                                                          8. South East Asia
                                                                                                                                          9. Rest of Asia-Pacific
                                                                                                                                        3. Middle East and Africa
                                                                                                                                          1. Middle East and Africa In Vivo CRO Market, By Type
                                                                                                                                            1. Rodent
                                                                                                                                              1. Non-Rodent
                                                                                                                                              2. Middle East and Africa In Vivo CRO Market, By Disease Indication
                                                                                                                                                1. Autoimmune/inflammation conditions
                                                                                                                                                  1. Pain management
                                                                                                                                                    1. Oncology
                                                                                                                                                      1. CNS conditions
                                                                                                                                                        1. Diabetes
                                                                                                                                                          1. Obesity
                                                                                                                                                            1. Others
                                                                                                                                                            2. Middle East and Africa In Vivo CRO Market, By GLP Type
                                                                                                                                                              1. Non GLP
                                                                                                                                                                1. GLP Toxicology
                                                                                                                                                                2. UAE
                                                                                                                                                                  1. UAE In Vivo CRO Market, By Type
                                                                                                                                                                    1. Rodent
                                                                                                                                                                      1. Non-Rodent
                                                                                                                                                                      2. UAE In Vivo CRO Market, By Disease Indication
                                                                                                                                                                        1. Autoimmune/inflammation conditions
                                                                                                                                                                          1. Pain management
                                                                                                                                                                            1. Oncology
                                                                                                                                                                              1. CNS conditions
                                                                                                                                                                                1. Diabetes
                                                                                                                                                                                  1. Obesity
                                                                                                                                                                                    1. Others
                                                                                                                                                                                    2. UAE In Vivo CRO Market, By GLP Type
                                                                                                                                                                                      1. Non GLP
                                                                                                                                                                                        1. GLP Toxicology
                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                    3. LATAM
                                                                                                                                                                                      1. LATAM In Vivo CRO Market, By Type
                                                                                                                                                                                        1. Rodent
                                                                                                                                                                                          1. Non-Rodent
                                                                                                                                                                                          2. LATAM In Vivo CRO Market, By Disease Indication
                                                                                                                                                                                            1. Autoimmune/inflammation conditions
                                                                                                                                                                                              1. Pain management
                                                                                                                                                                                                1. Oncology
                                                                                                                                                                                                  1. CNS conditions
                                                                                                                                                                                                    1. Diabetes
                                                                                                                                                                                                      1. Obesity
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                        2. LATAM In Vivo CRO Market, By GLP Type
                                                                                                                                                                                                          1. Non GLP
                                                                                                                                                                                                            1. GLP Toxicology
                                                                                                                                                                                                            2. Brazil
                                                                                                                                                                                                              1. Brazil In Vivo CRO Market, By Type
                                                                                                                                                                                                                1. Rodent
                                                                                                                                                                                                                  1. Non-Rodent
                                                                                                                                                                                                                  2. Brazil In Vivo CRO Market, By Disease Indication
                                                                                                                                                                                                                    1. Autoimmune/inflammation conditions
                                                                                                                                                                                                                      1. Pain management
                                                                                                                                                                                                                        1. Oncology
                                                                                                                                                                                                                          1. CNS conditions
                                                                                                                                                                                                                            1. Diabetes
                                                                                                                                                                                                                              1. Obesity
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. Brazil In Vivo CRO Market, By GLP Type
                                                                                                                                                                                                                                  1. Non GLP
                                                                                                                                                                                                                                    1. GLP Toxicology
                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                              Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                                              Get This Report

                                                                                                                                                                                                                              Download Free Sample

                                                                                                                                                                                                                              Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                                              The button will be active once the above form is filled

                                                                                                                                                                                                                              Our Clients:

                                                                                                                                                                                                                              LG Electronics
                                                                                                                                                                                                                              AMCAD Engineering
                                                                                                                                                                                                                              KOBE STEEL LTD.
                                                                                                                                                                                                                              Hindustan National Glass & Industries Limited
                                                                                                                                                                                                                              Voith Group
                                                                                                                                                                                                                              International Paper
                                                                                                                                                                                                                              Hansol Paper
                                                                                                                                                                                                                              Whirlpool Corporation
                                                                                                                                                                                                                              Sony
                                                                                                                                                                                                                              Samsung Electronics
                                                                                                                                                                                                                              Qualcomm
                                                                                                                                                                                                                              Google
                                                                                                                                                                                                                              Fiserv
                                                                                                                                                                                                                              Veto-Pharma
                                                                                                                                                                                                                              Nippon Becton Dickinson
                                                                                                                                                                                                                              Merck
                                                                                                                                                                                                                              Argon Medical Devices
                                                                                                                                                                                                                              Abbott
                                                                                                                                                                                                                              Ajinomoto
                                                                                                                                                                                                                              Denon
                                                                                                                                                                                                                              Doosan
                                                                                                                                                                                                                              Meiji Seika Kaisha Ltd
                                                                                                                                                                                                                              LG Chemicals
                                                                                                                                                                                                                              LCY chemical group
                                                                                                                                                                                                                              Bayer
                                                                                                                                                                                                                              Airrane
                                                                                                                                                                                                                              BASF
                                                                                                                                                                                                                              Toyota Industries
                                                                                                                                                                                                                              Nissan Motors
                                                                                                                                                                                                                              Neenah
                                                                                                                                                                                                                              Mitsubishi
                                                                                                                                                                                                                              Hyundai Motor Company

                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                              Address:
                                                                                                                                                                                                                              Office 515 A, Amanora Chambers,
                                                                                                                                                                                                                              Amanora Park Town, Hadapsar,
                                                                                                                                                                                                                              Pune 411028, Maharashtra, India.
                                                                                                                                                                                                                              Contact Us:
                                                                                                                                                                                                                              +1 646 905 0080 (U.S.)
                                                                                                                                                                                                                              +91 8087085354 (India)
                                                                                                                                                                                                                              +44 203 695 0070 (U.K.)

                                                                                                                                                                                                                              sales@straitsresearch.com

                                                                                                                                                                                                                              Quick Links
                                                                                                                                                                                                                              Help
                                                                                                                                                                                                                              Verified. Protected. Secure.
                                                                                                                                                                                                                              DMCA.com Protection Status
                                                                                                                                                                                                                              Secure Payments:
                                                                                                                                                                                                                              Follow Us:
                                                                                                                                                                                                                              www.straitsresearch.com © Copyright . All rights Reserved.